Marcus Axelsson (M Axelsson, Markus Axelsson)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 10

Top Venues

Acta neurologica Scandinavica

Journal of neurology

Proceedings of the National Academy of Sciences of the United States of America

Brain and behavior

Sahlgenska university hospital

Goteborgs Universitet Sahlgrenska Akademin (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sahlgenska university hospital May 01 2003

Sweden

Senior MD

Education History

Goteborgs Universitet Sahlgrenska Akademin - May 03 2013

Sweden

PHD

Publications

Kalle Johansson, Pontus Wasling, Marcus Axelsson
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy. Acta neurologica Scandinavica 144 (5) (2021)
Simone Hjæresen, Tobias Sejbæk, Marcus Axelsson, Helle Vinsløv-Jensen, Sif Kløvedal Mortensen, Gorm Pihl-Jensen, Lenka Novakova, Julie Damgaard Rosgaard Christensen, Christian Bonde Pedersen, Bo Halle, Frantz Rom Poulsen, Jette Lautrup Frederiksen, Mengliang Zhang, Eirkiur Benedikz, Jan N Lycke, Zsolt Illes, Åsa Fex Svenningsen
The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis. Journal of neurology 268 (9) (2021)
Daniel Jons, Henrik Zetterberg, Clas Malmeström, Tomas Bergström, Marcus Axelsson, Kaj Blennow, Måns Thulin, Peter Sundström, Oluf Andersen
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis. Acta neurologica Scandinavica 142 (2) (2020)
Jesse Huang, Mohsen Khademi, Lars Fugger, Örjan Lindhe, Lenka Novakova, Marcus Axelsson, Clas Malmeström, Clara Constantinescu, Jan N Lycke, Fredrik Piehl, Tomas Olsson, Ingrid Kockum
Inflammation-related plasma and CSF biomarkers for multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 117 (23) (2020)
Johan Zelano, Marcus Axelsson, Radu Constantinescu, Clas Malmeström, Eva Kumlien
Neuronal antibodies in adult patients with new-onset seizures: A prospective study. Brain and behavior 9 (11) (2019)
Radu Constantinescu, Ubah Mahamud, Clara Constantinescu, Barbro Eriksson, Lenka Novakova, Bob Olsson, Lars Rosengren, Kaj Blennow, Marcus Axelsson
Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases. Acta neurologica Scandinavica 140 (3) (2019)
Sofia Thunström, Marcus Axelsson
Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report. BMC neurology 19 (1) (2019)
Marcus Axelsson, Nicolas Dubuisson, Lenka Novakova, Clas Malmeström, Gavin Giovannoni, Jan Lycke, Sharmilee Gnanapavan
Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies. Acta neurologica Scandinavica 139 (5) (2019)
Radu Constantinescu, Lars Rosengren, Barbro Eriksson, Kaj Blennow, Marcus Axelsson
Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. Acta neurologica Scandinavica 140 (2) (2019)
Marcus Axelsson, M Sjögren, Oluf Andersen, K Blennow, H Zetterberg, J Lycke
Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study. Acta neurologica Scandinavica 138 (2) (2018)

Marcus Axelsson.css-eqlu8i{font-size:small;padding-left:4px;} (M Axelsson, Markus Axelsson)

Publication Activity (10 Years)

Top Topics

Top Venues

Marcus Axelsson (M Axelsson, Markus Axelsson)